Pharmaceutical Executive - Pharmaceutical news and analysis. Pharma management, sales, marketing & finance

ADVERTISEMENT

Previous Story Play / Pause Next Story
New & Noteworthy
Pre-emption and States' Rights
Pharma backs federal standards for compassionate use, drug importing, data transparency, and track-and-trace. Jill Wechsler reports.
The Peace Dividend
A surprising takeaway from the recent BIO Convention, writes William Looney, is the stark contrast between cooperative industry engagement and an unstable geopolitical order.
WebMD: The Patient Value Equation
WebMD CEO David Schlanger tells PharmExec how connecting patients with physicians through a robust digital platform can deliver quality of care, cost savings, and better health outcomes.

Latest Pharm Exec Videos

Events
Facility Design, Innovation and Qualification
July 29, 2014 - July 31, 2014
Philadelphia, PA USA

Speed to Therapy
August 12, 2014 - August 13, 2014
Philadelphia, PA USA

8th Annual Forum on Transparency and Aggregate Spend
August 18, 2014 - August 20, 2014
Washington, DC USA

Roche Reports Good Half-Year Performance
Pharm Exec's 2014 Dealmakers Outlook
Compounding Pharmacy Issues Recall, But Challenges FDA Decision
European Pharma Races to Catch Up with Data Protection
Pharma Rep Access Down 33 Per Cent Since 2008
Shire Takeover "Could Save AbbVie $8 Billion Tax on Humira over Next 15 Years"
Marketing Peter HoustonFocusing on the Metrics That Matter
Opinion Tom NortonPharmaco Desertion: Is Something Wrong with the US Tax System?
From the Editor William LooneyBehind This Year's Pharma Top 50
Global ReflectorEuropean Industry Teams with Parallel Traders to Fight Counterfeiters
 More
Survey
The FDA Safety & Innovation Act (FDASIA) was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
33%
Breakthrough designations
17%
Protecting the supply chain
33%
Expedited reviews of drug submissions
11%
More stakeholder involvement
6%
View Results
PHARM EXEC GLOBAL DIGEST
Pharmaceutical Executive Digest EuropeTo read the latest issue of Pharm Exec Global Digest
Click here. Click here to receive the Digest into your inbox every month.
Click here